ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Freedom Broker trims Pinduoduo price target on China demand concerns

Analysts lower targets amid mixed earnings and competitive pressures in China’s e-commerce sector. Stock trades at $87.33 as P/E ratio stands at 9.1.

PA
Priya Anand · Equities & Earnings Desk · 30 Aug 2026 · 08:33 · 1 min read
Share
Freedom Broker trims Pinduoduo price target on China demand concerns

Freedom Broker reduced its price target for Pinduoduo Inc. to $150 from $160, citing mixed second-quarter 2026 results and weaker-than-expected domestic demand in China. The brokerage maintained its Buy rating on the stock, which was trading at $87.33 at the time of the report.

Benchmark also lowered its price target for Pinduoduo to $114 from $127 while keeping its Buy recommendation. The adjustments follow Pinduoduo’s reported adjusted earnings per share of $19.33, exceeding Wall Street estimates of $18.35 by 5.34%. Revenue, however, fell short at $112.36 billion against expectations of $113.90 billion, a miss of 1.35%. The company’s P/E ratio was noted at 9.1.

Analysts highlighted several headwinds, including weak domestic demand in China and intensified competition within the e-commerce sector. Pinduoduo has increased spending on merchant support, logistics infrastructure, and ecosystem development to bolster growth. Regulatory pressures and rising logistics costs in overseas markets further complicate its international expansion strategy, particularly in maintaining Temu’s price competitiveness. Benchmark emphasized that domestic operational constraints, such as merchant support and ecosystem investments, have weighed on monetization efforts.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
ADVERTISEMENT